mirage

Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

ABACUS/Manakin Repository

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)